Get the Stockscreener App
7.87
1.37%
-0.14
Profound Medical Corp stock is traded at $7.87, with a volume of 10,272.
It is down -1.37% in the last 24 hours and up +1.94% over the past month.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
See More
Previous Close:
$8.01
Open:
$8
24h Volume:
10,272
Relative Volume:
0.21
Market Cap:
$196.06M
Revenue:
$8.98M
Net Income/Loss:
$-31.39M
P/E Ratio:
-5.7445
EPS:
-1.37
Net Cash Flow:
$-24.83M
1W Performance:
-3.19%
1M Performance:
+1.94%
6M Performance:
-4.70%
1Y Performance:
-25.89%
1-Day Range:
$7.77
$8.00
1-Week Range:
$7.67
$8.2575
52-Week Range:
$7.11
$11.69
Profound Medical Corp Stock (PROF) Company Profile
Name
Profound Medical Corp
Sector
Industry
Phone
-
Address
-
Compare PROF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| PROF | 7.90 | 196.06M | 8.98M | -31.39M | -24.83M | -1.37 |
| ABT | 117.54 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 392.11 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.70 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.92 | 112.92B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 70.07 | 40.88B | 6.60B | 4.16B | 490.10M | 2.34 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-21-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-15-20 | Initiated | Jefferies | Buy |
Profound Medical Corp Stock (PROF) Latest News
GAGNON SECURITIES LLC Acquires Shares in Profound Medical Corp - GuruFocus.com
Tom Tamberrino Joins Profound Medical as Chief Commercial Officer - MPO-mag
Opportunity Arises for Co. With Cell Pouch - Streetwise Reports
Profound Medical Corp. Announces Executive Changes - Marketscreener.com
Profound Medical to Present at Stifel Conference - TipRanks
Profound Medical to Participate in the Stifel 2024 Healthcare Conference - The Manila Times
Fact check: Are late-term abortions ever ‘medically necessary’? - Al Jazeera English
Profound Medical Corp. (NASDAQ:PROF) Q3 2024 Earnings Call Transcript - Insider Monkey
What is Raymond James' Forecast for TSE:PRN FY2028 Earnings? - MarketBeat
FY2028 Earnings Forecast for PROF Issued By Raymond James - MarketBeat
Profound Medical Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Profound Medical Corp (PROF) Q3 2024 Earnings Call Highlights: R - GuruFocus.com
Profound Medical Corp (PROF) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses - Yahoo Finance
Interventional Oncology Market Global Latest Trends and Insights 2024 to 2031 - Newstrail
A fantastic week for Profound Medical Corp.'s (TSE:PRN) 50% institutional owners, one-year returns continue to impress - Simply Wall St
Profound Medical (PROF) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Profound Medical Announces Third Quarter 2024 Financial Results - The Manila Times
10 Best Hearing Aids of November 2024: Expert Reviewed - National Council on Aging
Leede Financial Predicts TSE:PRN FY2024 Earnings - Defense World
Profound Medical Corp (TSX:PRN) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Praxis Precision Medicines, Inc. (PRAX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Leede Financial Comments on TSE:PRN FY2024 Earnings - MarketBeat
FY2024 Earnings Forecast for PROF Issued By Leede Financial - MarketBeat
Revolutionary AI Tools Take Center Stage in Medical Education Symposium - Streetwise Reports
Medical Co. Ready for a Transformative F2025 - Streetwise Reports
Canada Market top gains: Step Energy Services Ltd. gains 40.17% while Arizona Metals Corp. rises 16.67% at midday - Business Upturn
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025 - The Manila Times
When (PROF) Moves Investors should Listen - Stock Traders Daily
Profound Medical (TSX:PRN) Ending Cash Position : C$46.71 Mil (As of Jun. 2024) - GuruFocus.com
Profound Medical (PROF) to Release Quarterly Earnings on Thursday - MarketBeat
Profound Medical (PRN) Set to Announce Earnings on Thursday - MarketBeat
Learn to Evaluate (PROF) using the Charts - Stock Traders Daily
Profound Medical (TSE:PRN) Trading Down 0.2%Here's What Happened - MarketBeat
PainReform (NASDAQ:PRFX) Shares Up 11% – Here’s Why - Defense World
E.Merge Technology Acquisition (OTCMKTS:ETACU) Trading Down 1.5% – Here’s Why - Defense World
Profound Medical (NASDAQ:PROF) Trading Down 0.1%Here's What Happened - MarketBeat
Profound Medical to Release Third Quarter 2024 Financial Results on November 7Conference Call to Follow - The Manila Times
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference ... - The Hastings Tribune
Profound Medical Corp (PROF-Q) QuotePress Release - The Globe and Mail
Nevro announces new inducement grants - Medical Buyer
Tom Tamberrino named Profound Medical CCO - Medical Buyer
Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer - Wallaceburg Courier Press
Economic Sector Performance Dashboards - Yahoo Finance
Debut Memoir by Visually Impaired Author, Jamie Roth, Makes Bestseller: 'I Lost One Vision, But Gained Another' - Yahoo Finance
iCAD to Participate in the LD Micro Main Event XVII - Newsfile
Trend Tracker for (PROF) - Stock Traders Daily
Owning 50% shares,institutional owners seem interested in Profound Medical Corp. (TSE:PRN), - Yahoo Finance
Profound Medical Corp (PROF) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance UK
ROME Therapeutics, Enara Bio, Nucleome Therapeutics and NYU Langone Health to Host 3rd Annual Dark Genome Symposium - ForexTV.com
iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024 - Yahoo Finance
How to Take Advantage of moves in (PROF) - Stock Traders Daily
Profound Medical Corp Stock (PROF) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):